Macrobrachium rosenbergii disease-resistant immune related gene Lamp1 and application thereof

Characterization of the Lamp1 gene in Macrobrachium rosenbergii addresses the molecular mechanism of DIV1 infection, enabling effective detection and cultivation of resistant shrimp varieties, thus reducing disease-related economic losses.

CN119061020AInactive Publication Date: 2024-12-03YANGZHOU UNIV

Patent Information

Application Number
CN202411433305.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

There is a lack of understanding of the molecular mechanism of viral infection and host response to Decapod iridescent virus 1 (DIV1) in Macrobrachium rosenbergii, leading to significant economic losses in the shrimp industry due to high mortality rates from this acute infectious disease.

Method used

Characterization of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii, including its nucleotide and amino acid sequences, and development of an expression vector, recombinant bacterium, and primer set for detecting DIV1 infection, along with a kit for identifying DIV1 resistance in shrimps.

Benefits of technology

The gene Lamp1 is upregulated in immune response to DIV1 infection, enabling effective detection and identification of DIV1-resistant shrimp varieties, facilitating screening and cultivation for disease resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061020A_ABST
    Figure CN119061020A_ABST
Patent Text Reader

Abstract

The invention discloses a macrobrachium rosenbergii disease-resistant immune related gene Lamp1 and application thereof. The nucleotide sequence of the macrobrachium rosenbergii disease-resistant immune related gene Lamp1 is shown as SEQ ID NO. 1. The invention provides the macrobrachium rosenbergii disease-resistant immune related gene Lamp1 which can respond to DIV1 and has high expression characteristic in the immune response of macrobrachium rosenbergii infected with DIV1, and the gene plays an important role in the immune defense process of resisting DIV1 infection of macrobrachium rosenbergii. After healthy macrobrachium rosenbergii is infected with DIV1, the expression level of the macrobrachium rosenbergii disease-resistant immunity related gene Lamp1 is remarkably increased, so that the macrobrachium rosenbergii disease-resistant immunity related gene Lamp1 can be used for detecting whether the macrobrachium rosenbergii is infected with DIV1 or not, the technical problem that the viral diseases of the macrobrachium rosenbergii are difficult to monitor is solved, and the application prospect is wide. The method can be used for identifying the anti-DIV1 level of macrobrachium rosenbergii individuals, so that screening and breeding of macrobrachium rosenbergii DIV1-resistant varieties are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of aquatic animal molecular biology, and particularly relates to a disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii and an application thereof. Background Art

[0002] Shrimp iridovirus disease is an acute, infectious disease that infects crustaceans. Its pathogen is a new genus of the Iridoviridae family, the Decapod iridescent virus 1 (DIV1), which belongs to the genus Iridovirus. The virus has the characteristics of rapid transmission, wide host range, and high mortality rate, causing great economic losses to the Macrobrachium rosenbergii industry. At present, some research has been carried out on the etiology, pathology, epidemiology, detection and diagnosis of DIV1 disease, but there is a lack of in-depth understanding of the molecular mechanism of viral infection and the host's response rules.

[0003] The Lamp family is a type I transmembrane protein. These proteins are not only present on the lysosomal membrane, but also widely distributed in the endomembrane system of the cell, including the plasma membrane, Golgi apparatus, endoplasmic reticulum and various vesicles. There are currently five members of the Lamp family: Lamp1, Lamp2, Lamp3, Lamp4 and Lamp5. Lamp family proteins play a vital role in the recognition, fusion and release of lysosomes. Lamp1 and Lamp2 are two highly glycosylated proteins that are the main components of the lysosomal membrane. As a digestive factory in the cell, lysosomes not only play a key role in the normal physiological activities of cells, such as digestion, phagocytosis and autophagy, but also play an important role in innate immune defense. In invertebrates, lysosomes can effectively remove invading pathogens through their phagocytic function, thereby protecting the host from infection. In recent years, many studies have reported that Lamp1 plays an important role in endocytosis, lysosomal function, lipid metabolism and immune response. Lamp1 was originally thought to protect the lysosomal membrane from digestion by hydrolases. In human cells, Lamp1 and Lamp2 jointly recruit RAB7 protein, participate in the fusion process of phagosomes and lysosomes, and affect the maturation of phagosomes. Lamp1 can participate in the movement of phagosomes on microtubules, which is essential for the transport and distribution of intracellular substances. In Drosophila, the loss of Lamp1 leads to an increase in the number of lysosomes and plays a role in lipid metabolism, affecting the levels of sterols and diacylglycerols. In Japanese shrimp, Lamp1 may serve as a membrane receptor for white spot syndrome virus (WSSV)-infected shrimp, mediating the endocytosis and intracellular transport of the virus. However, there is no report on the anti-DIV1 innate immune response of Macrobrachium rosenbergii disease-resistant immunity-related gene Lamp1. In order to further explore the biological function of Lamp1 in the innate immune defense of crustaceans, it is necessary to characterize and study the related functions of Macrobrachium rosenbergii disease-resistant immunity-related gene Lamp1. Summary of the invention

[0004] Technical problems solved: In response to the above technical problems, the present invention provides a disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii and its application. By analyzing its immune function against DIV1, it provides a reference for exploring the function of Lamp1 in shrimp resistance to pathogen infection, enriching the basic theoretical research on Lamp1 function and antiviral immunity.

[0005] Technical solution: In the first aspect, the present invention provides a disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii, the nucleotide sequence of which is shown in SEQ ID NO.1, and the amino acid sequence of the encoded protein is shown in SEQ ID NO.2:

[0006] SEQ ID NO.1:

[0007]

[0008] SEQ ID NO.2:

[0009] MAKLIAFAFALLFACGSVIGQDDTTIEPDTTLPPEPPTTVPLTTEAPITEPPATTTAPPEPETTTAPETTVPPEPETTTAAPVPDTTTAPVPVTTPAPEANYNYNITENNVTCIMIEGAVTFLVNYTTVNNETKTATVVLPKHPKANSVITGTCNGTDGQEEI QVTWGPAGQSSSVKVEFGVKGDSWSVSSFVANLFMDPVTFANGTDAGKTLSLDVDYGFSPLSVPVNHSFNCHSSLSAVNITATIGGAPYSLGVSSKLDGIHIQAYNMVPYEPDFVSSVHCSADEISDVVPIAVGCALAALVVIVLIAYLVGRRRRSAAYQSV.

[0010] In a second aspect, the present invention provides an expression vector comprising the disease resistance immunity-related gene Lamp1 of the Macrobrachium rosenbergii described in the first aspect.

[0011] In a third aspect, the present invention provides a recombinant bacterium comprising the expression vector described in the second aspect.

[0012] In a fourth aspect, the present invention provides a recombinant Escherichia coli comprising the expression vector described in the second aspect.

[0013] In a fifth aspect, the present invention provides a primer set for detecting viral infection of Macrobrachium rosenbergii, the primer set being used to detect the expression level of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii according to claim 1; the viral infection includes decapod iridescent virus 1 (DIV1) infection, and the nucleotide sequence of the primer set is shown in SEQ ID NO.3-SEQ ID NO.4:

[0014] SEQ ID NO.3: ATGGCTAAATTAATCGCCTTCG;

[0015] SEQ ID NO. 4: TTAAACAGACTGGTATGCAGC.

[0016] In a sixth aspect, the present invention provides a kit for detecting Macrobrachium rosenbergii virus infection, comprising the primer set described in the fifth aspect.

[0017] In a seventh aspect, the present invention provides a kit for identifying the ability of Macrobrachium rosenbergii to resist infection by decapod iridescent virus 1 (DIV1), characterized in that it comprises the primer set described in claim 5.

[0018] In an eighth aspect, the present invention provides the use of the disease-resistant immunity-related gene Lamp1 of Macrobrachium rosenbergii described in the first aspect, or the expression vector described in the second aspect, or the recombinant bacteria described in the third aspect, or the recombinant Escherichia coli described in the fourth aspect in the preparation of an agent for Macrobrachium rosenbergii to control Decapoda iridescent virus 1.

[0019] Beneficial effects: The present invention provides a Macrobrachium rosenbergii disease resistance immunity-related gene Lamp1 that can respond to DIV1 and has a high expression characteristic in the immune response of Macrobrachium rosenbergii infected with DIV1. This gene plays an important role in the immune defense process of Macrobrachium rosenbergii against DIV1 infection. When healthy Macrobrachium rosenbergii is infected with DIV1, the expression level of Macrobrachium rosenbergii disease resistance immunity-related gene Lamp1 is significantly upregulated. Therefore, Macrobrachium rosenbergii disease resistance immunity-related gene Lamp1 can be used to detect whether Macrobrachium rosenbergii is infected with DIV1, which solves the technical problem of the difficulty in monitoring viral diseases of Macrobrachium rosenbergii, and can be used to identify the anti-DIV1 level of Macrobrachium rosenbergii individuals, thereby realizing the screening and cultivation of Macrobrachium rosenbergii DIV1-resistant varieties. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is a schematic diagram of the electrophoresis identification results of the recombinant clone plasmid pMD19T-Lamp1, where M represents DL 2000DNAMarker; lanes 1-3 represent the amplified products of PCR using the plasmid as a template; lane 4 represents the negative control;

[0021] Figure 2 The figure shows the nucleotide sequence and deduced amino acid sequence analysis results of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii, including a conserved Lamp domain, two disulfide bonds, a signal peptide sequence, a transmembrane region and a Motif;

[0022] Figure 3 The figure is the result of amino acid sequence analysis of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii, where A is the secondary structure prediction of Lamp1 protein, and B is the tertiary structure prediction of Lamp1 protein;

[0023] Figure 4 This is the phylogenetic tree analysis result of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii;

[0024] Figure 5 This is the result of multiple sequence comparison analysis of the amino acid sequence of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii;

[0025] Figure 6 This is a schematic diagram of the distribution of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii in different tissues of healthy shrimp;

[0026] Figure 7 This is a schematic diagram of the expression of the disease resistance-related immune gene Lamp1 in the gills of Macrobrachium rosenbergii at different time points after DIV1 infection;

[0027] Figure 8 This is a schematic diagram of the expression of the disease-resistant immunity-related gene Lamp1 in the hepatopancreas of Macrobrachium rosenbergii at different time points after DIV1 infection;

[0028] Fig. 9 This is a schematic diagram of the expression of the disease resistance-related immune gene Lamp1 in the hemolymph of Macrobrachium rosenbergii at different time points after DIV1 infection;

[0029] Fig.10 Schematic diagram of the expression of disease-resistant immunity-related gene Lamp1 in the intestine of Macrobrachium rosenbergii at different time points after DIV1 infection. DETAILED DESCRIPTION

[0030] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments:

[0031] Example 1: Construction of recombinant cloning plasmid of Macrobrachium rosenbergii disease resistance immunity-related gene Lamp1

[0032] The average weight of Macrobrachium rosenbergii was 7.22±0.46 g, which was purchased from Yangzhou Fuyuan Aquatic Products Co., Ltd. Before the experiment, Macrobrachium rosenbergii was temporarily cultured in a 2×1×0.5m 3 The aquarium was placed in the aquarium for 2 weeks to adapt to the environment. The dissolved oxygen was maintained above 5 mg / L, the water temperature was 28-31°C, the water was changed by 1 / 3 every day, and the feed was given twice a day. Nine adult shrimps were randomly selected, and their hemolymph, muscle, hepatopancreas, gills and intestines were taken. The tissues of three healthy shrimps were mixed in a centrifuge tube, and all the collected samples were stored at -80°C.

[0033] use The RNA of the above samples was extracted using the PrimeScript Plus kit (Beijing Quanshijin Biotechnology Co., Ltd.), and the experiments were carried out according to the instructions. The concentration, purity and integrity of the extracted RNA were determined using an ultraviolet spectrophotometer and agarose gel electrophoresis, respectively. cDNA was synthesized using the PrimeScript TMRT reverse transcription kit (Beijing Quanshijin Biotechnology Co., Ltd.) and stored in a -20°C refrigerator for future use.

[0034] Oligo 7 software was used to design Lamp1-F and Lamp1-R specific primers (as shown in SEQ ID NO.3 and SEQ ID NO.4 in Table 1), and sent to Shanghai Biotech for synthesis. Then, Lamp1 was amplified using the above hepatopancreas cDNA as a template, and the PCR product was detected by 1% agarose gel electrophoresis. The target gene fragment was recovered using a gel recovery kit and connected to the pMD-19T vector. The ligation product was transformed into DH5α competent cells, inoculated in LB solid medium (containing ampicillin), and cultured at 37°C for 12 hours. The positive clones were sequenced and analyzed by Shanghai Biotech.

[0035] Table 1 Experimental related primers

[0036]

[0037] The electrophoresis identification results of the obtained recombinant clone plasmid pMD19T-Lamp1 are as follows Figure 1 As shown, M represents DL2000 DNA Marker; lanes 1-3 represent the amplified products obtained by PCR using the plasmid as a template; lane 4 represents the negative control, and it can be seen that the recombinant cloning plasmid pMD19T-Lamp1 was successfully constructed.

[0038] Example 2: Functional analysis of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii

[0039] The nucleotide sequence of Lamp1 was translated into an amino acid sequence using the ExPASy tool (https: / / www.expasy.org / ), and the amino acid sequence is shown in SEQ ID NO.2. The main protein domains were predicted using the NCBI Conserved Domain (CDD) database (https: / / www.ncbi.nlm.nih.gov / cdd / ) and the SMART tool (https: / / smart.embl.de / ). Hydrophilicity analysis was performed using ProtScale (https: / / web.expasy.org / protscale / ). Signal peptides were predicted using the SignalP 4.1 website (https: / / services.healthtech.dtu.dk / services / SignalP-4.1 / ). The transmembrane region of Lamp1 was predicted using the TMHMM 2.0 program (https: / / services.healthtech.dtu.dk / services / TMHMM-2.0 / ). Specific structural sites were analyzed using PSORTⅡ (https: / / psort.hgc.jp / form2.html). The secondary structure was predicted using the SOMPA online program (https: / / npsa-prabi.ibcp.fr / cgi-bin / npsa_automat.pl?page=npsa%20_sopma.html), and the three-dimensional structure was analyzed using the SWISS-MODEL website (https: / / swissmodel.expasy.org / ). Multiple sequence alignment was performed using Clustal X 2.0 software. In addition, a phylogenetic tree was constructed using the neighbor-joining method (NJ) based on the MEGA 7 program (1000 bootstraps were set). The experimental results are shown in Figure 2. Figure 2 to Figure 5 shown.

[0040] Figure 2 The nucleotide sequence and deduced amino acid sequence analysis results of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii. Among them, there are 1 conserved Lamp domain, 2 disulfide bonds, 1 signal peptide sequence, 1 transmembrane structure region and 1 Motif (Y represents a tyrosine residue, X represents any amino acid residue, Representing large hydrophobic amino acid residues) are indicated by blue underlines and green, red, blue, and dark grey boxes, respectively. Figure 3 The figure in the middle shows the amino acid sequence analysis results of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii. Among them, A is the secondary structure prediction of Lamp1 protein, and B is the tertiary structure prediction of Lamp1 protein. Figure 4This is the result of phylogenetic tree analysis of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii. Figure 5 This is the result of multiple sequence comparison analysis of the amino acid sequence of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii.

[0041] Depend on Figure 2 and Figure 3 It can be seen that the nucleotide sequence of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii contains a complete open reading frame (ORF) with a full length of 978 bp, encoding 325 amino acid residues. The predicted molecular weight is 33.977 kDa, and the theoretical isoelectric point is 4.33. According to SMART and CDD predictions, Lamp1 has 1 conserved Lamp domain, 2 disulfide bonds, 1 signal peptide sequence, 1 transmembrane structure region and 1 Motif (Y represents a tyrosine residue, X represents any amino acid residue, (represents large hydrophobic amino acid residues). PSORT II analysis showed that Lamp1 has a conserved C-terminal cytoplasmic short peptide, about 11 amino acid residues long. In addition, the C-terminal cytoplasmic short peptide has 1 motif, adaptor protein 2 (AP-2) μ subunit can bind The motifs interact with each other, and the AP-2 complex can mediate the transport of LAMPS to lysosomes. The hydrophilicity prediction results show that the polypeptide chain of the disease-resistant immunity-related gene Lamp1 of Macrobrachium rosenbergii has both hydrophilic and hydrophobic regions, indicating that the protein is amphipathic. The transmembrane region prediction shows that Lamp1 has a transmembrane structure region (290-314aa), and 1-289aa is located on the outside of the cell, and 313-324aa is located on the inside of the cell. Signal peptide prediction analysis shows that Lamp1 has a signal peptide (1-20aa), which is speculated to be a secretory protein. Figure 3 In the secondary structure of Lamp1 protein in A, α-helix accounts for 6.8%, extended chain accounts for 33.2%, and random coil accounts for 60.0%. Homology modeling was performed using 6kyk.1.B as a template to construct Figure 3 The tertiary structure of Lamp1 protein in B shows that the content of random coil is the highest, which is consistent with the secondary structure prediction result.

[0042] Depend on Figure 4 and Figure 5It can be seen that the deduced amino acid sequence of the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii is 93.23%, 58.26%, 57.89%, 56.88%, 50.90%, 50.89%, 49.73%, 35.98% and 35.88% consistent with that of Macrobrachium nipponensis, Penaeus monodon, Penaeus nipponensis, Penaeus vannamei, Procambarus clarkii, Portunus trituberculatus, Drosophila barbatus, Homo sapiens and Mouse, respectively. The amino acid sequence comparison results showed that Lamp1s of different species were divided into two groups, namely Lamp1s of vertebrates and Lamp1s of invertebrates, and the amino acid sequence similarity of Lamp1s between different species was low, and only the transmembrane domain and C-terminal short peptide were similar. The phylogenetic tree showed that Macrobrachium rosenbergii and Macrobrachium nipponensis were clustered in one branch, and the accession number obtained after the sequence was uploaded to GenBank was XCZ50679.1.

[0043] The above results show that the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii encodes a protein of 325 amino acid residues with a conserved Lamp domain, signal peptide, transmembrane domain and The Lamp1 of Macrobrachium rosenbergii is highly similar to that of Macrobrachium nipponense, but has a lower similarity to other species.

[0044] Example 3: Animal experiment on the disease resistance and immunity-related gene Lamp1 of Macrobrachium rosenbergii

[0045] The examples provide the results of animal experiments on the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii.

[0046] Virus attack test: DIV1 was isolated from diseased Macrobrachium rosenbergii, which was sourced from a Macrobrachium rosenbergii farm in Jiangsu, China. The hepatopancreas, gill filaments, hemolymph, muscle, appendages, intestine and other tissues of diseased Macrobrachium rosenbergii were dissected and homogenized with sterile PBS buffer at a volume ratio of 1:10. The homogenate was centrifuged at 4°C and 10,000 rpm for 10 minutes, and the supernatant was collected and sterilized by filtering with a 0.22 μm filter membrane to obtain a crude virus extract. The concentration of DIV1 in the crude virus extract was calculated according to the above standard curve, and the initial concentration was 5.2×10 8 100 healthy Macrobrachium rosenbergii of similar size were randomly selected. The control group was injected with 100 μL of sterile phosphate buffered saline (PBS) in the second abdominal segment muscle, and the experimental group was injected with 100 μL of 5.2×10 5 The relevant tissues (hepatopancreas, gills, hemolymph, intestine and muscle) of three shrimps were collected at 0h, 12h, 24h, 48h, 72h and 96h after infection, and tissue RNA was extracted and cDNA was synthesized.

[0047] Real-time fluorescence quantitative PCR: The RT-qPCR method was used to analyze the expression pattern of Lamp1 in healthy or DIV1-infected tissues of Macrobrachium rosenbergii. The reaction system was 5 μL Taq SYBR Green qPCR Premix, 0.5 μL cDNA (100 ng / μL), 0.25 μL forward primer, 0.25 μL reverse primer and 4 μL enzyme-free water. The reaction procedure was: pre-denaturation at 95°C for 30 s, denaturation at 95°C for 10 s, annealing and extension at 60°C for 30 s, for a total of 40 cycles. The reaction was repeated 3 times to ensure the accuracy of the results. 18S was used as the internal reference gene (primer sequences are shown in SEQ ID NO.7-SEQ ID NO.8 in Table 1). Methods The relative expression of Lamp1 was analyzed by one-way analysis of variance using SPSS 26.0 software, supplemented by LSD test. The data were expressed as mean ± standard deviation (SD). Different lowercase letters indicate statistical significance. The experimental results are shown in Figure 6 to Figure 10 shown.

[0048] Figure 6 The distribution of the disease resistance-related immunity gene Lamp1 in different tissues of healthy Macrobrachium rosenbergii is shown in Figure 2. Figure 7 The expression of Lamp1 in the gills of Macrobrachium rosenbergii at different time points after DIV1 infection. Figure 8 The expression of Lamp1 in the hepatopancreas of Macrobrachium rosenbergii at different time points after DIV1 infection. Fig. 9 The expression of Lamp1 in the hemolymph of Macrobrachium rosenbergii at different time points after DIV1 infection. Fig.10 The expression of Lamp1 in the intestine of Macrobrachium rosenbergii at different time points after DIV1 infection.

[0049] Depend on Figure 7 to Figure 10 It can be seen that by injecting DIV1 into healthy Macrobrachium rosenbergii muscle, the expression level of Lamp1 in gills, hepatopancreas, hemolymph and intestine after infection was analyzed. The results showed that after DIV1 infection, Lamp1 mRNA in gills, hepatopancreas, hemolymph and intestine was significantly upregulated from 0 to 72 hours, and reached the maximum value at 72 hours, which increased by 27.80, 4.3, 72.28 and 60.09 times respectively compared with 0 hours, and then its expression was significantly downregulated from 72 to 96 hours, but the overall expression level was still higher than that at 0 hours.

[0050] The above results show that: 0-72h after DIV1 infection of healthy Macrobrachium rosenbergii, Lamp1 mRNA was significantly upregulated in the gills, hepatopancreas, hemolymph and intestine and reached the maximum value at 72h. Although it was downregulated at 72-96h, it was still higher than 0h.

[0051] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii, characterized in that: Its nucleotide sequence is shown in SEQ ID NO.

1.

2. An expression vector, characterized in that: The invention comprises the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii according to claim 1.

3. A recombinant bacterium, characterized in that: Comprising the expression vector according to claim 2.

4. A recombinant Escherichia coli, characterized in that Comprising the expression vector according to claim 2.

5. A primer set for detecting Macrobrachium rosenbergii virus infection, characterized in that: The primer set is used to detect the expression level of the disease resistance immunity-related gene Lamp1 of Macrobrachium rosenbergii according to claim 1; the nucleotide sequence of the primer set is shown in SEQ ID NO.3-SEQ ID NO.

4.

6. A kit for detecting Macrobrachium rosenbergii virus infection, characterized in that: Comprising the primer set of claim 5.

7. A kit for identifying the ability of Macrobrachium rosenbergii to resist infection by decapod iridovirus 1, characterized in that: Comprising the primer set of claim 5.

8. Use of the disease-resistant immunity-related gene Lamp1 of Macrobrachium rosenbergii according to claim 1, or the expression vector according to claim 2, or the recombinant bacteria according to claim 3, or the recombinant Escherichia coli according to claim 4 in the preparation of an agent for preventing and controlling decapoda iridovirus 1 of Macrobrachium rosenbergii.

Citation Information

Patent Citations

  • Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof

    CN105007941A

  • LAMP (Loop-mediated Isothermal Amplification) detection primer group, kit and method for shrimp blood cell iridovirus

    CN112795702A

  • Iridovirus DNA vaccine

    CN116640787A

Cited By

  • Tilapia mossambica disease-resistant immune related gene and application thereof

    CN117660466A

  • SNP sites related to resistance of macrobrachium rosenbergii iridovirus disease, site combination and application of SNP sites and site combination

    CN119410843A

  • Peritrophic membrane factor recombinant protein for enhancing ability of macrobrachium rosenbergii to resist decapod iridovirus and application of peritrophic membrane factor recombinant protein

    CN121574222A

  • Recombinant protein of peritrophic membrane factor for enhancing the ability of macrobrachium rosenbergii to resist decapod iridescent virus and application thereof

    CN121574222B